Literature DB >> 17241746

Focal cerebral ischemia/reperfusion injury in mice induces hematopoietic prostaglandin D synthase in microglia and macrophages.

M Liu1, N Eguchi, Y Yamasaki, Y Urade, N Hattori, T Urabe.   

Abstract

Hematopoietic prostaglandin D synthase is a key enzyme in synthesis of prostaglandin D. Hematopoietic prostaglandin D synthase is expressed in microglia of the developing mouse brain. This study determined the serial changes and cellular localization of hematopoietic prostaglandin D synthase, and its role in cerebral ischemia/reperfusion injury using C57BL/6 mice (n=84) and bone marrow chimera mice (n=16). The latter mice were selected based on their expression of enhanced green fluorescent protein in bone marrow/blood-derived monocytes/macrophages. The middle cerebral artery was occluded for 60 min, followed by reperfusion. Hematopoietic prostaglandin D synthase expression was examined by immunohistochemistry and Western blotting. Hematopoietic prostaglandin D synthase-positive cells were mainly expressed in the peri-ischemic area at 12 h (P<0.05) and 24 h (P<0.001) after reperfusion, while they were mostly found in the transition area at 48-72 h postreperfusion (P<0.001). There was a significant increase in staining intensity as well as number of hematopoietic prostaglandin D synthase-positive cells in the ischemic core at 5-7 (P<0.001) days postreperfusion. Hematopoietic prostaglandin D synthase-positive cells also co-expressed ionized calcium-binding adapter molecule 1, a marker of microglia/macrophages, and cyclooxygenase-2, but not markers of neurons, oligodendrocytes and astrocytes. Until 72 h postreperfusion, many enhanced green fluorescent protein-positive cells were negative for hematopoietic prostaglandin D synthase, but the number of hematopoietic prostaglandin D synthase-enhanced green fluorescent protein coexpressing cells increased significantly at 5-7 days after reperfusion. Our results indicate that hematopoietic prostaglandin D synthase is mainly produced by endogenous microglia until 72 h after reperfusion, but at 7 days after reperfusion, it is also produced by migrating bone marrow/blood-derived macrophages in the ischemic brain tissue. We speculate that hematopoietic prostaglandin D synthase in the brain has different functions during early and late phases of ischemia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17241746     DOI: 10.1016/j.neuroscience.2006.12.018

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  6 in total

1.  The flavonoid fisetin attenuates postischemic immune cell infiltration, activation and infarct size after transient cerebral middle artery occlusion in mice.

Authors:  Mathias Gelderblom; Frank Leypoldt; Jan Lewerenz; Gabriel Birkenmayer; Denise Orozco; Peter Ludewig; John Thundyil; Thiruma V Arumugam; Christian Gerloff; Eva Tolosa; Pamela Maher; Tim Magnus
Journal:  J Cereb Blood Flow Metab       Date:  2012-01-11       Impact factor: 6.200

2.  Altered regulation of CD200 receptor in monocyte-derived macrophages from individuals with Parkinson's disease.

Authors:  Xiao-Guang Luo; Ji-Juan Zhang; Chao-Dong Zhang; Rong Liu; Lan Zheng; Xi-Jin Wang; Sheng-Di Chen; Jian-Qing Ding
Journal:  Neurochem Res       Date:  2010-04       Impact factor: 3.996

3.  The changing phenotype of microglia from homeostasis to disease.

Authors:  Xiao-Guang Luo; Sheng-Di Chen
Journal:  Transl Neurodegener       Date:  2012-04-24       Impact factor: 8.014

4.  Hematopoietic-Prostaglandin D2 synthase through PGD2 production is involved in the adult ovarian physiology.

Authors:  Andalib Farhat; Pascal Philibert; Charles Sultan; Francis Poulat; Brigitte Boizet-Bonhoure
Journal:  J Ovarian Res       Date:  2011-02-25       Impact factor: 4.234

5.  Topical Administration of a Soluble TNF Inhibitor Reduces Infarct Volume After Focal Cerebral Ischemia in Mice.

Authors:  Minna Yli-Karjanmaa; Bettina Hjelm Clausen; Matilda Degn; Hans Gram Novrup; Ditte Gry Ellman; Peter Toft-Jensen; David E Szymkowski; Allan Stensballe; Morten Meyer; Roberta Brambilla; Kate Lykke Lambertsen
Journal:  Front Neurosci       Date:  2019-08-07       Impact factor: 4.677

6.  Lack of sphingomyelin synthase 2 reduces cerebral ischemia/reperfusion injury by inhibiting microglial inflammation in mice.

Authors:  Yu Yang; Fengxian Hu; Guifeng Yang; Qingmei Meng
Journal:  Exp Ther Med       Date:  2020-10-22       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.